Pharmacist Digest

WuXi and BIO’s grip-and-grin

STAT

APRIL 18, 2024

Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. China tension tests new BIO CEO When John Crowley took over as BIO’s CEO, all was fine and dandy with WuXi AppTec, which was then a member of the trade group.

Unified vision essential in UK advanced manufacturing

European Pharmaceutical Review

NOVEMBER 14, 2023

This ‘manifesto for growth’, developed by the Manufacturing Five (M5), a coalition of the UK’s leading advanced trade associations, proposed the reforms necessary for the UK to close the gap with global competitors and growth of innovative manufacturing in the country. Article: Are we globally prepared for the next pandemic?

Pharmaceutical Manufacturing

Recap: 2023 Washington Representatives Retreat

Putting Patients First Blog

NOVEMBER 27, 2023

Recap: 2023 Washington Representatives Retreat November 27, 2023 By: Bhriana Onuoha, Senior Coordinator, Communications Last week, over 100 policy professionals from the National Health Council’s (NHC) membership gathered in Annapolis, MD, for the NHC’s annual Washington Representatives Retreat. Fishman led the Latest from CMMI session.

Communication

US frets over pharma supply chain security

pharmaphorum

JUNE 22, 2022

Ben Hargreaves finds out how the issue of foreign manufacturing has become a major US political talking point and how this could influence the pressures facing the industry. In recent years, this has become a major talking point within US politics. Security of supply.

Generic Medicine

Generic Medicine Vaccines

Affordability is tied to quality

Express Pharma

AUGUST 16, 2023

African leaders are now committing to policies that recognise that production capabilities are essential for the continent in the future. They now face the challenge of providing their manufacturers with the policy framework and long-term financial support needed to develop technology and survive. It was there before the pandemic.

Vaccines

Vaccines Compounding

Innovation and collaboration – the MHRA’s pandemic approach

pharmaphorum

NOVEMBER 24, 2021

The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients. The Government has committed to relooking at regulation as it determines its own independent trading policy.

Vaccines

Vaccines Documentation

Sentiment towards Brexit has worsened three years after UK left EU

Pharmaceutical Technology

MAY 31, 2023

Policy and measurements had been established to minimise the negative influence of Brexit such as the EU–UK Trade and Cooperation Agreement (TCA), UK Medicines and Medical Devices Act, and the extended Horizon Europe Guarantee scheme to provide support to Horizon Europe applicants from the UK.

Frost renews call to exclude medicines from Northern Ireland Brexit rules

The Guardian - Pharmaceutical Industry

JANUARY 19, 2023

Industry figures warn of supply ‘cliff edge’ when new regulations come into effect in December 2023 Lord Frost has renewed calls for medicines to be excluded from the Brexit trading rules in Northern Ireland amid claims that supplies could be threatened in December when regulation of pharmaceuticals in the UK further diverges from the EU.

Twenty Women Leaders In Healthcare Industry

PharmaShots

MARCH 9, 2023

Schaeffer Center for Health Policy and Economics at the University of Southern California and the Leadership Consortium of the National Academy of Medicine. Other Affiliations: Jennifer is the Board of Directors member in Pharmaceutical Research and Manufacturers of America. She also sits on the Advisory Board of the Leonard D.

Clinical Pharmacology

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies

The Once and Future FDA Commissioner

Eye on FDA

NOVEMBER 18, 2021

Though, of course, it is a very different political climate and a different Senate than it was the first time. For all of 2021 trade media have carried headlines about the fact that this regulatory pathway is under attack and FDA officials have stepped up to defend the program. It would therefore seem to be even less of an issue today.

Communication

Communication Pharmaceutical Companies Pharmaceutical Companies

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

Despite this, Brazil’s trade protectionist policies mean that there are few pharmaceutical companies of international origin within the country. In emerging markets around the world, regulatory, economic, and political barriers can impede the availability of certain pharmaceuticals, supplements, and diagnostics.

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

JUNE 8, 2020

Dave (HR): Well to me, you know again this real market, people are getting great care and great outcomes and the physicians, surgery centers and so on are very happy and thriving economically and so there’s a fair trade if you will, between the two parties in the kind of this rigged sort of PPO market.

Health and Personal Care Stores

Health and Personal Care Stores Mayo Clinic Hospitals Specialty Pharmacies

How do you solve a problem like Bedoya?

Ramblings of a pharmacist

FEBRUARY 18, 2022

Especially when they’re about charged political issues. Five months ago, President Joe Biden appointed Alvaro Bedoya as the 5th member of the Federal Trade Commission. But the FTC doesn’t set immigration policy. And when they (even indirectly) disparage powerful politicians. Mr. Bedoya was born in Peru.

Grocery Stores

Grocery Stores Specialty Pharmacies Drug Pricing Documentation